LoginSignup
Tecan Group logo

Tecan Group

Stock
Stock
ISIN: CH0012100191
Ticker: TECN
CH0012100191
TECN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 21.04.2026

$1.957

CHART BY

Frequently asked questions

What is Tecan Group's market capitalization?

The market capitalization of Tecan Group is $1.85B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Tecan Group?

Tecan Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$11.07. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Tecan Group's stock?

Currently, 9 analysts cover Tecan Group's stock, with a consensus target price of $205.13. Analyst ratings provide insights into the stock's expected performance.

What is Tecan Group's revenue over the trailing twelve months?

Over the trailing twelve months, Tecan Group reported a revenue of $1.12B.

Is Tecan Group paying dividends?

Yes, Tecan Group is paying dividends. The next payment is scheduled for 21.04.2026, with an expected amount of .

How many employees does Tecan Group have, and what sector and industry does it belong to?

Tecan Group employs approximately 3,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Tecan Group's shares?

The free float of Tecan Group is 12.29M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.85B
EPS (TTM) 
-$11.07
Free Float 
12.29M
Revenue (TTM) 
$1.12B

Pricing

1D span
$144.92$160.81
52W span
$140.67$220.53

Analyst Ratings

The price target is $205.13 and the stock is covered by 9 analysts.

Buy

3

Hold

6

Sell

0

Information

Tecan Group AG operates as a holding company. The firm engages in the development, production and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the following segments: Life Sciences Business and Partnering Business. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded on March 18, 1980 and is headquartered in Mannedorf, Switzerland.

Employees
3,000
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
CH0012100191
Primary Ticker
TECN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin